ARRB1 and primary biliary cholangitis: In liver, ARRB1 could enhance hepatocellular carcinogenesis through inflammation‐mediated AKT signalling15; in addition, ARRB1 could modulate the functions of autoimmune T cells in primary biliary cirrhosis patients.16